Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Buy Us a Coffee
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2009-1334
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Cross-site scripting (XSS) vulnerability in login/FilepathLogin.html in IBM Tivoli Continuous Data Protection (CDP) for Files 3.1.4.0 allows remote attackers to inject arbitrary web script or HTML via the reason parameter.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM Tivoli CDP 'login/FilepathLogin.html'跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
Tivoli Continuous Data Protection for Files是用于保护文件的连续备份软件。 Tivoli Continuous Data Protection for Files的login/FilepathLogin.html页面没有正确地过滤reason参数输入便返回给了用户，远程攻击者可以通过向服务器提交恶意请求执行跨站脚本攻击，导致在用户浏览器会话中执行任意HTML和脚本代码。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2009-1334
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2009-1334
Please Login to view more intelligence information
IV. Related Vulnerabilities
Same product: n/a
Same vendor: n/a
V. Comments for CVE-2009-1334

No comments yet

Leave a comment